No Data
Hongbo Pharmaceuticals (301230.SZ) plans to grant 1.23 million restricted stocks at a grant price of 12.35 yuan per share.
Hongbo Pharmaceutical (301230.SZ) disclosed the 2024 Restricted Stock Incentive Plan (draft), the company plans to award restricted stocks to incentivize employees, with a total of 400 participants participating.
Hongbo Pharmaceutical: Report for the third quarter of 2024
Hongbo Pharma (301230.SZ) released its performance for the first three quarters, with a net income of 15.2436 million yuan, a 66.81% year-on-year decrease.
Hongbo Medicine (301230.SZ) released the third quarter report for the first three quarters of 2024, during the reporting period the company achieved revenue...
Hongbo Pharmaceuticals (301230.SZ): In the first half of 2024, a dividend of 1 yuan per 10 shares will be distributed. The ex-dividend date is October 24th.
Golden 汇October 17th丨Hongbo Pharmaceutical (301230.SZ) announced that the company's interim equity distribution plan for the first half of 2024 is as follows: based on the total share capital of the company, excluding the repurchased 2,046,200 shares, the remaining 137,540,405 shares will be distributed to all shareholders at a rate of 1.0 RMB cash per 10 shares. The equity registration date is October 23, 2024, and the ex-rights and ex-dividend date is October 24, 2024.
Hengbo Pharmaceuticals (301230.SZ): Cumulatively repurchased 1.4659% of shares.
On October 9th, GeLongHui reported that as of September 30, 2024, the company has repurchased a total of 2,046,200 shares through a designated securities account for centralized competitive trading, accounting for 1.4659% of the company's current total share capital of 139,586,605 shares. The highest fill price was 37.68 yuan per share, the lowest fill price was 19.78 yuan per share, with a total fill amount of 53,075,305.42 yuan (excluding transaction fees).
PharmaResources (Shanghai) Co., Ltd. (SZSE:301230) Stocks Shoot Up 43% But Its P/S Still Looks Reasonable
Declining Stock and Decent Financials: Is The Market Wrong About PharmaResources (Shanghai) Co., Ltd. (SZSE:301230)?No Data
No Data
